Skip to content

Rare Diseases: Top 50 Drugs By Global Sales

February 26, 2014

In the February 2014 issue of Medical Marketing & Media, the publication reviews the trend of new products for rare diseases that are “improvements over those which exist”, the role and influence of advocacy groups, and the engagement of the patient community. The article also identifies the top 50 orphan drug brands by worldwide sales. In 2012, per the article (according to data from EvaluatePharma), the global sales of the top 50 orphan drug products rose by 9% to $69.9 billion and forecasts that orphan drugs will account for approximately 16% of global Rx sales by 2018 (excluding generics).

The following chart shows the top 10 of the 50 rare disease products ranked by 2012 global sales :

Top 10 Rare Disease Drugs By Global Sales

Rank

Product

Manufacturer

US    Sales

($ Millions) *

# of FDA Orphan Drug Designations (ODDs) **

1

Rituxan Roche

$7,155.3

4

2

Gleevec Novartis

$4,675.0

7

3

Neulasta Amgen

$4,092.0

1

4

Copaxone Teva

$3,996.0

3

5

Revlimid Celgene

$3,766.6

6

6

Avonex Biogen   Idec

$2,913.1

4

7

Alimta Eli Lilly

$2,594.3

1

8

Rebif Merck   KGaA

$2,433.4

2

9

Advate Baxter   International

$2,074.5

0

10

Tracleer Actelion

$1,600.5

3

.

* Sales, EvaluatePharma (per MM&M article chart); ** # of FDA ODDs from FDA’s Orphan Drug Product Designation Database (added by the Orphan Druganaut Blog).

For rankings #11 – #50, please reference the article.

Observations

•   Alexion Pharmaceuticals’ Soliris is ranked #19

•   Several products for Hemophilia: Advate, NovoSeven, Kogenate, BeneFIX, ReFacto AF/Xyntha, FEIBA VH, and Helixate

•   Several products for Lysosomal Storage Disorders (LSDs): Cerezyme, Myozyme, Elaprase, and Replagal.

Please Note: “Abstract pills” by Robson# (Flickr: Pills here) [CC-BY-2.0] | Wikimedia Commons.

Copyright © 2012-2014, Orphan Druganaut Blog. All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: